UnitedHealth Group Incorporated UNH

October 01, 2026--UnitedHealthcare today introduced its 2027 Medicare Advantage plans, designed to bring affordability, simplicity and a more connected care experience to a growing and increasingly diverse population of beneficiaries. As America’s most chosen Medicare brand for 18 years in a row1, the company's Medicare portfolio continues to focus on delivering the benefits members value most while advancing new ways to make healthcare more accessible, personalized and easier to use.

Healthcare stocks declined late Wednesday afternoon with the NYSE Healthcare Index and the State Str

A federal judge in Minnesota granted in part and denied in part UnitedHealth's (UNH) motion to dismi

Her surgeon is scheduled, her prior authorization is approved, and her surgery date is locked in for January. What her insurer has not told her could unravel all three.

Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.

UnitedHealth Group (NYSE:UNH) has appointed Robert Hunter as president of UnitedHealthcare as part of a leadership realignment. The new UnitedHealthcare chief is expected to help advance a multi-year plan focused on margin recovery and modernization of operations. Hunter’s remit includes restoring confidence among regulators and customers while sharpening the business’s digital experience across key insurance offerings. The Robert Hunter appointment at UnitedHealthcare is important, but...

– Hatteras holds first closing of Hatteras Opportunity Fund II (HOF II) – – HOF II closing brings capital under management to over $1 billion – DURHAM, N.C., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Hatteras Venture Partners, a venture capital firm focused on transformative healthcare innovation, has appointed two longtime healthcare leaders to senior roles as it builds its next generation of companies and expands support for later-stage portfolio businesses. Sir Andrew Witty, former Chief Executive O

UnitedHealth Group Incorporated (NYSE:UNH) is getting a new head of its insurance division, with executive Robert Hunter disclosing on September 28 that he will take the role. Hunter announced it himself in a post on LinkedIn, and the firm has issued no comments on the reasoning. The division he is taking over is the one […]

UnitedHealth (UNH) stock trades at 22.5 times its past year's adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock's 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on.

Robert Hunter will focus on UnitedHealthcare’s “modernization agenda” in the new role. It’s the latest in a slew of leadership changes at UnitedHealth as the company works to restore its image.

UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding now depends on costs that management has not yet fully tamed.

UnitedHealth will release its third-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 46.9% over the past six months, topping the S&P 500 by 25.5 percentage points.

A retired man collects Social Security and a pension, adds $1,000 a month from a popular Treasury fund, and ends up handing the IRS a bill he never needed to pay. The fund type is the culprit, and the fix is hiding in plain sight.

CorVel Corporation (NASDAQ:CRVL) has quietly turned the unglamorous niche of risk management and healthcare cost containment into a relentless cash compounding machine. Backed by steady multi-year top-line growth that expanded annual revenue to nearly $$959 million in fiscal 2026, CorVel’s capital-light model generates exceptionally high returns on invested capital while converting a massive percentage of […]